The MGM buy is not his moneyKeith A. Meister · Director, MGM Resorts International; managing partner, Corvex Management LP
| Date | Code | Shares | Wtd avg | Range | Owned after | D/I |
|---|---|---|---|---|---|---|
| 30 Oct 2026 | P | 233,998 | $28.92 | $28.41–29.40 | 5,581,976 | I |
| 30 Oct 2026 | P | 1,504,076 | $29.75 | $29.41–29.96 | 7,086,052 | I |
| 2 Nov 2026 | P | 7,518 | $30.24 | $30.23–30.25 | 7,093,570 | I |
- What they did
- 1,745,592 shares bought on the open market for $51,740,827, lifting the reported position from 5,347,978 to 7,093,570 — up 32.6%. Footnotes 2 and 3: the shares are held for Corvex Master Fund LP, Corvex Select Equity Master Fund LP and Corvex-E LP, and the reporting person “disclaims beneficial ownership except to the extent of his pecuniary interest.”
Consensus read
An activist director backed up the truck at a 52-week low two days after a bad quarter. Biggest insider buy of the day, no 10b5-1 plan to hide behind, a 32.6% lift in the stake.
Insider conviction that the Las Vegas softness is cyclical and the stock is mispriced — the cleanest bullish signal on the tape this week.
Contrarian read
The headline is wrong about whose money this is, and the “no plan” point is backwards. This is three Corvex funds adding to a position; the manager’s own exposure is limited to his pecuniary interest in them, and he expressly disclaims the rest.
It is a fund allocation reported on an individual’s form because he sits on the board — not a principal putting $52M of personal net worth behind a call.
Evidence that discriminates
- The ownership column. I on all three rows, with footnotes naming three Corvex funds. That single field is what separates a personal conviction buy from a fund trade, and it is unambiguous on the face of the document. At least one widely syndicated summary of this exact filing reported the holding as directly owned — the opposite of what the form says. The error is the story.
- The unticked 10b5-1 box carries almost no signal here. MGM reported Q3 on 28 October and held its call on 29 October. He bought on 30 October — the first clear day of the post-earnings window. A sitting director buying in the window immediately after a print is the base rate, not the exception, and plan cover is for people who want to trade outside it.
- Size relative to the vehicle, not the man. 7,093,570 shares is 2.82% of the 251,601,576 shares outstanding at 30 September. The purchase does not approach the 5% Schedule 13D threshold, so it creates no new disclosure duty and implies no stake-building toward control.
Why he bought is not knowable from this document
Three live hypotheses, with what separates them:
- A value call by the fund’s process on the Las Vegas cycle. Predicts nothing further.
- Rebuilding toward a strategic push — MGM has retired close to half its share count in five years and Meister’s board history includes the ad-hoc real-estate committee. Predicts a 13D, a strategic review, or a board action within two quarters.
- Mechanical — inflows or a reweighting after a drawdown. Predicts similar-sized adds across several Corvex names in the same week; Corvex funds have been filing open-market Form 4s in GeneDx, so the cross-name test is actually checkable.
What would falsify me
A Form 4 or Schedule 13D showing Meister acquiring MGM shares in his own name with D in the ownership column, or a Corvex 13D on MGM. Either would make this a principal-level bet and not a fund allocation, and the consensus read would be closer to right than mine.
Also: if MGM’s next proxy discloses a director stock-ownership requirement he was satisfying, the “whose money” question changes shape again.
Pattern vs his own historyThe last comparably sized Corvex transaction in MGM ran the other way — a negotiated sale of 9 million shares back to MGM and IAC, announced January 2022. Direction reversed; vehicle unchanged. The 7,518-share print on 2 November at a two-cent range is almost certainly a completion tail of the 30 October order rather than a second decision.